Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 2 of 1338 results
Sort by: relevance publication year
Showing results for ISSN matching 1758-8359

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

JOURNAL ARTICLE published January 2021 in Therapeutic Advances in Medical Oncology

Research funded by Eli Lilly and Company (NA) | Roche (na)

Authors: Isabelle Monnet | Alain Vergnenègre | Gilles Robinet | Henri Berard | Regine Lamy | Lionel Falchero | Sabine Vieillot | Roland Schott | Charles Ricordel | Stephane Chouabe | Pascal Thomas | Radj Gervais | Anne Madroszyk | Samir Abdiche | Anne Marie Chiappa | Laurent Greillier | Chantal Decroisette | Jean Bernard. Auliac | Christos Chouaïd | the GFPC 02-13 (METAL2) investigators

https://doi.org/10.1177/17588359211006983 Actions

Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

JOURNAL ARTICLE published January 2023 in Therapeutic Advances in Medical Oncology

Research funded by National Natural Science Foundation of China (72074123) | Joint Funds for the innovation of science and Technology, Fujian province (2021Y9208)

Authors: Ying-Tao Lin | Chong-Chong Zhou | Kai Xu | Meng-Die Zhang | Xin Li

https://doi.org/10.1177/17588359231213621 Actions

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”

JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology

https://doi.org/10.1177/1758835920932317 Actions

RETRACTED: The effect of CELLFOODTM on radiotherapy or combined chemoradiotherapy: preclinical evidence

JOURNAL ARTICLE published January 2019 in Therapeutic Advances in Medical Oncology

Authors: Barbara Nuvoli | Bruno Amadio | Giancarlo Cortese | Serena Benedetti | Barbara Antoniani | Antonella Soriani | Mariantonia Carosi | Lidia Strigari | Rossella Galati

https://doi.org/10.1177/1758835919878347 Actions

To exploit the 5 ‘R’ of radiobiology and unleash the 3 ‘E’ of immunoediting: ‘RE’-inventing the radiotherapy-immunotherapy combination

JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology

Authors: Elisabeth Daguenet | Jonathan Khalifa | Alain Tolédano | Delphine Borchiellini | Yoann Pointreau | Claire Rodriguez-Lafrasse | Cyrus Chargari | Nicolas Magné

https://doi.org/10.1177/1758835920913445 Actions

Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions

JOURNAL ARTICLE published January 2023 in Therapeutic Advances in Medical Oncology

Authors: Sondos Zayed | Alexander V. Louie | Daniel A. Breadner | David A. Palma | Rohann J. M. Correa

https://doi.org/10.1177/17588359231183668 Actions

Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology

https://doi.org/10.1177/1758835920913426 Actions

Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis

JOURNAL ARTICLE published January 2019 in Therapeutic Advances in Medical Oncology

Authors: Ji Cheng | Ming Cai | Xiaoming Shuai | Jinbo Gao | Guobin Wang | Kaixiong Tao

https://doi.org/10.1177/1758835919838963 Actions

A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy

JOURNAL ARTICLE published April 2017 in Therapeutic Advances in Medical Oncology

Authors: Mariana S. Sousa | Michelle Peate | Sherin Jarvis | Martha Hickey | Michael Friedlander

https://doi.org/10.1177/1758834016687260 Actions

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology

Authors: Shun Lu | Ying Cheng | Dingzhi Huang | Yuping Sun | Lin Wu | Chengzhi Zhou | Ye Guo | Jingxin Shao | Wanli Zhang | Jianying Zhou

https://doi.org/10.1177/17588359221105020 Actions

Diagnostic value of [99mTc]Tc-PSMA-I&S-SPECT/CT for the primary staging and restaging of prostate cancer

JOURNAL ARTICLE published January 2024 in Therapeutic Advances in Medical Oncology

Authors: István Farkas | Gábor Sipka | Annamária Bakos | Anikó Maráz | Zoltán Bajory | Zsófia Mikó | Tamás Czékus | Szabolcs Urbán | Linda Varga | László Pávics | Zsuzsanna Besenyi

https://doi.org/10.1177/17588359231221342 Actions

Corrigendum to “Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach”

JOURNAL ARTICLE published January 2021 in Therapeutic Advances in Medical Oncology

https://doi.org/10.1177/17588359211034059 Actions

Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”

JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology

https://doi.org/10.1177/17588359221108536 Actions

Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?

JOURNAL ARTICLE published March 2015 in Therapeutic Advances in Medical Oncology

Authors: Onur Telli | Hasmet Sarici | Musa Ekici | Berat Cem Ozgur | Omer Gokhan Doluoglu | Muzaffer Eroglu | Tugba Akin Telli

https://doi.org/10.1177/1758834014560158 Actions

Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna

JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology

Authors: Philipp Melhorn | Elisabeth Kretschmer-Chott | Ladislaia Wolff | Alexander Haug | Peter Mazal | Markus Raderer | Barbara Kiesewetter

https://doi.org/10.1177/17588359221138389 Actions

The role of abemaciclib in treatment of advanced breast cancer

JOURNAL ARTICLE published 1 January 2018 in Therapeutic Advances in Medical Oncology

Research funded by Breast Cancer Research Foundation (BCRF-17-037)

Authors: Amelia McCartney | Erica Moretti | Giuseppina Sanna | Marta Pestrin | Emanuela Risi | Luca Malorni | Laura Biganzoli | Angelo Di Leo

https://doi.org/10.1177/1758835918776925 Actions

Estimating the 95% confidence interval for survival gain between an experimental anti-cancer treatment and a control

JOURNAL ARTICLE published November 2017 in Therapeutic Advances in Medical Oncology

Authors: Andrea Messori | Erminia Caccese | Maria Claudia D’Avella

https://doi.org/10.1177/1758834017731084 Actions

Therapeutic options in older patients with metastatic non-small cell lung cancer

JOURNAL ARTICLE published September 2012 in Therapeutic Advances in Medical Oncology

Authors: Elisabeth Quoix

https://doi.org/10.1177/1758834012455838 Actions

Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma

JOURNAL ARTICLE published January 2011 in Therapeutic Advances in Medical Oncology

Authors: Geertjan van Tienhoven | Dirk J. Gouma | Dick J. Richel

https://doi.org/10.1177/1758834010383150 Actions

Corrigendum

JOURNAL ARTICLE published November 2017 in Therapeutic Advances in Medical Oncology

https://doi.org/10.1177/1758834017743368 Actions
Feedback: support@crossref.org